GPT and chronic hepatitis B virus infection: In this study, we aimed to constructed a noninvasive model based on serum markers to accurately identify moderate and severe inflammation or significant fibrosis related to CHB, which is helpful to the decision-making of antiviral treatment in patients with chronic hepatitis B with ALT < 2 ULN and to reduce the need for liver biopsy as much as possible.